NIH-funded research R21 grant

Advanced ultrasound technology for better evaluation of rheumatoid arthritis

Official title: Ultrasensitive Doppler Ultrasound for Evaluation of Rheumatoid Arthritis

Funded at Mayo Clinic Rochester · NIH-10659056 · Data updated 2026-11-12

This study is testing a new ultrasound technology called HUMI that aims to better detect inflammation in the joints of people with rheumatoid arthritis, helping doctors provide more accurate treatment based on what they find.

More Ultrasound research and trials

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionMayo Clinic Rochester
NIH-funded
Lab location1 site (Rochester, United States)
Project startJuly 10, 2022
Project endJune 30, 2025
Funding year2023
Award (this year)$209,880
NIH project number5R21AR076028-02
Project IDNIH-10659056 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with rheumatoid arthritis who require regular assessments of joint inflammation.

Less likely to help

Patients with rheumatoid arthritis who are not undergoing regular evaluations or those with other unrelated conditions may not benefit from this research.

What this research studies

This research focuses on developing a new ultrasound technology called High-sensitivity Ultrasound Microvessel Imaging (HUMI) to improve the evaluation of synovial inflammation in patients with rheumatoid arthritis (RA). Current methods like MRI and traditional Doppler ultrasound have limitations in sensitivity and cost, which can lead to underdiagnosis. The HUMI technology aims to provide a more accurate and comprehensive assessment by detecting microvessels in 3D with high sensitivity, using advanced imaging techniques and algorithms. This could lead to better management of RA by guiding therapy more effectively based on precise evaluations.

Why it matters

Potential benefit: If successful, this research could lead to more accurate diagnoses and improved treatment strategies for patients with rheumatoid arthritis.

How similar studies have gone: Other research has shown promising results with advanced ultrasound technologies in similar applications, indicating potential for success in this novel approach.

Where this research is happening

  • Mayo Clinic Rochester
    Rochester, United States
    Active

Researchers

  • Principal investigator: Chen, Shigao — Mayo Clinic Rochester
  • Study coordinator: Chen, Shigao

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.